title: [Microbial secondary metabolites as potential reserve of pharmaceuticals].
abstract: The major characteristics of new bioactive microbial secondary metabolites are summarized in the review. A wide range of new molecular targets are implicated in discovery of new nonantibiotic compounds with some other pharmacological activities (noninfectious diseases). Microorganisms represent fascinating resources due to their production of novel products with broad spectra of bioactivities.
authors.forename: T I
authors.initials: TI
authors.lastname: Orlova
authors.forename: V G
authors.initials: VG
authors.lastname: Bulgakova
authors.forename: A N
authors.initials: AN
authors.lastname: Polin
mesh_terms: D000900:Anti-Bacterial Agents / Q000302:isolation & purification / Q000494:pharmacology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000302:isolation & purification / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000302:isolation & purification / Q000494:pharmacology; D000998:Antiviral Agents / Q000302:isolation & purification / Q000494:pharmacology; D001419:Bacteria / Q000737:chemistry / Q000378:metabolism*; D001685:Biological Factors / Q000302:isolation & purification / Q000494:pharmacology*; D055808:Drug Discovery; D004791:Enzyme Inhibitors / Q000302:isolation & purification / Q000494:pharmacology; D005658:Fungi / Q000737:chemistry / Q000378:metabolism*; D000960:Hypolipidemic Agents / Q000302:isolation & purification / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D001685:Biological Factors; D004791:Enzyme Inhibitors; D000960:Hypolipidemic Agents